[{"address1": "1800 Sierra Point Parkway", "address2": "Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 484 0899", "website": "https://dayonebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Bender M.B.A., Ph.D.", "age": 53, "title": "CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 1048400, "exercisedValue": 0, "unexercisedValue": 64677}, {"maxAge": 1, "name": "Mr. Charles N. York II, M.B.A.", "age": 47, "title": "COO, CFO & Secretary", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 760000, "exercisedValue": 0, "unexercisedValue": 24599}, {"maxAge": 1, "name": "Mr. Adam  Dubow J.D.", "age": 57, "title": "General Counsel and Chief Compliance Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 608200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Stubenrauch Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaa  Roberson", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Davy  Chiodin Ph.D., Pharm.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren  Merendino M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elly  Barry M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.19, "open": 8.19, "dayLow": 7.93, "dayHigh": 8.26, "regularMarketPreviousClose": 8.19, "regularMarketOpen": 8.19, "regularMarketDayLow": 7.93, "regularMarketDayHigh": 8.26, "payoutRatio": 0.0, "beta": -1.389, "forwardPE": -7.205357, "volume": 577166, "regularMarketVolume": 577166, "averageVolume": 1166929, "averageVolume10days": 971810, "averageDailyVolume10Day": 971810, "bid": 8.03, "ask": 8.13, "bidSize": 1, "askSize": 2, "marketCap": 817934848, "fiftyTwoWeekLow": 7.88, "fiftyTwoWeekHigh": 18.07, "priceToSalesTrailing12Months": 6.236113, "fiftyDayAverage": 10.5985, "twoHundredDayAverage": 13.066725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 288812960, "profitMargins": -0.72808, "floatShares": 71972855, "sharesOutstanding": 101355000, "sharesShort": 17024478, "sharesShortPriorMonth": 17497763, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.168, "heldPercentInsiders": 0.16965, "heldPercentInstitutions": 0.94598, "shortRatio": 11.31, "shortPercentOfFloat": 0.2027, "impliedSharesOutstanding": 101355000, "bookValue": 4.972, "priceToBook": 1.6230892, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -95496000, "trailingEps": -1.02, "forwardEps": -1.12, "enterpriseToRevenue": 2.202, "enterpriseToEbitda": -1.371, "52WeekChange": -0.5006188, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 8.07, "targetHighPrice": 36.0, "targetLowPrice": 24.0, "targetMeanPrice": 31.125, "targetMedianPrice": 32.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 531720000, "totalCashPerShare": 5.246, "ebitda": -210708000, "totalDebt": 2602000, "quickRatio": 7.428, "currentRatio": 7.656, "totalRevenue": 131161000, "debtToEquity": 0.518, "revenuePerShare": 1.407, "returnOnAssets": -0.27673, "returnOnEquity": -0.22488001, "grossProfits": 125882000, "freeCashflow": -133987752, "operatingCashflow": -78113000, "grossMargins": 0.95975, "ebitdaMargins": -1.60648, "operatingMargins": -2.23678, "financialCurrency": "USD", "symbol": "DAWN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1743193200, "regularMarketTime": 1743192001, "regularMarketChangePercent": -1.4652002, "regularMarketPrice": 8.07, "shortName": "Day One Biopharmaceuticals, Inc", "longName": "Day One Biopharmaceuticals, Inc.", "postMarketChangePercent": 0.0, "postMarketPrice": 8.07, "postMarketChange": 0.0, "regularMarketChange": -0.119999886, "regularMarketDayRange": "7.93 - 8.26", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1166929, "fiftyTwoWeekLowChange": 0.18999958, "fiftyTwoWeekLowChangePercent": 0.024111621, "fiftyTwoWeekRange": "7.88 - 18.07", "fiftyTwoWeekHighChange": -10.0, "fiftyTwoWeekHighChangePercent": -0.55340344, "fiftyTwoWeekChangePercent": -50.061882, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622122200000, "epsTrailingTwelveMonths": -1.02, "epsForward": -1.12, "epsCurrentYear": -1.40054, "priceEpsCurrentYear": -5.762063, "fiftyDayAverageChange": -2.5285006, "fiftyDayAverageChangePercent": -0.23857154, "twoHundredDayAverageChange": -4.996725, "twoHundredDayAverageChangePercent": -0.38240072, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-27", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "exchange": "NMS", "messageBoardId": "finmb_704589075", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "displayName": "Day One Biopharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]